Pharmacokinetic and pharmacodynamic trials for medication development in SUD. September 25, 2023 to september 24, 2028. N01DA-23-8935.
Active Indefinite Delivery Contract Awarded Last action
- Contract number
- 75N95023D00019
- Awardee
-
Altasciences Clinical Kansas Inc. UEI WZ5RGEMMQ3W9
- Awarding agency
-
National Institute on Drug Abuse
National Institutes of Health, Department of Health and Human Services
- Task orders
- 3 $5,206,922 obligated
Award facts
- Opportunity
-
- Pharmacokinetic and Pharmacodynamic Trials for Medication Development in SUD Pre-Solicitation · 75N95023R00002 · Posted Jul 19, 2022
- Combined order value
- $5,206,922 Current and potential, with all options
- Last date to order 62% complete
- IDV ceiling 25% used
- $21,000,000.00
- Maximum order
- $21,000,000.00
- Award type
- Single award
- Who can order
- Only the awarding agency
- NAICS code
- 541715 Research and Development in the Physical, Engineering, and Life Sciences (except Nanotechnology and Biotechnology)
- Set-aside
- No set-aside
- Competition
- Full and Open Competition · 1 offer Negotiated Proposal / Quote
- Pricing
- Firm Fixed Price
- Legislative mandates
-
- Employment Eligibility Verification (E-Verify) FAR subpart 22.18
- Service Contract Inventory FAR subpart 4.17
Award details come from SAM.gov/FPDS.
About this IDV
The Department of Health and Human Services National Institutes of Health National Institute on Drug Abuse (NIDA) awarded a single-award $21 million indefinite delivery contract to Altasciences Clinical Kansas Inc., a contract research organization, to conduct pharmacokinetic and pharmacodynamic trials for medication development in substance use disorders.
Under this contract, NIDA issued a $1,838,615 firm fixed price delivery order to Altasciences to perform Phase 1 cocaine drug interaction trials from September 2023 through March 2025 in Overland Park, Kansas. The purpose of this contract is to provide clinical pharmacology research services to support NIDA's mission of advancing treatments for substance use disorders. No set-asides were used for this award.
Task orders
Quick answers
Who was awarded contract 75N95023D00019?
75N95023D00019 was awarded to Altasciences Clinical Kansas Inc. by National Institute on Drug Abuse (National Institutes of Health) on September 25, 2023.
How much is contract 75N95023D00019 worth?
Orders under 75N95023D00019 have obligated $5,206,922. 75N95023D00019's own ceiling is $21,000,000. A single order can be worth up to $21,000,000.
How many orders have been placed under contract 75N95023D00019?
3 orders have been placed under 75N95023D00019, the latest on May 2, 2025.
Who can order from contract 75N95023D00019?
75N95023D00019 is a single award indefinite delivery contract. Only the awarding agency can place orders on it.
Was contract 75N95023D00019 competed?
The extent of competition for 75N95023D00019 was full and open competition. The government received 1 offer.
On GovTribe
See this IDV's full record
- Every order and transaction
- The awardee's other awards and teaming partners
- Similar IDVs and recompete opportunities
- Ask GovTribe AI about this IDV